Please login to the form below

Not currently logged in


This page shows the latest satralizumab news and features for those working in and with pharma, biotech and healthcare.

Roche’s Soliris rival Enspryng bags FDA approval

Roche’s Soliris rival Enspryng bags FDA approval

Enspryng ( satralizumab) has been approved to treat adult patients living with anti-aquaporin-4 (AQP4) antibody positive NMOSD, a rare autoimmune disorder of the central nervous system which is often misdiagnosed

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...